Total Payments
$28,046
2024 Payments
$2,464
Companies
8
Transactions
35
Payment Breakdown by Category
Other$25,143 (89.6%)
Consulting$2,585 (9.2%)
Food & Beverage$318.29 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $18,563 | 21 | 66.2% |
| Compensation for serving as faculty or as a speaker for a medical education program | $6,345 | 3 | 22.6% |
| Consulting Fee | $2,585 | 1 | 9.2% |
| Food and Beverage | $318.29 | 9 | 1.1% |
| Honoraria | $235.00 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Emmaus Medical, Inc. | $18,611 | 23 | $0 (2024) |
| Global Blood Therapeutics, Inc. | $9,198 | 6 | $0 (2022) |
| BOSTON SCIENTIFIC CORPORATION | $83.26 | 1 | $0 (2018) |
| Medtronic MiniMed, Inc. | $47.14 | 1 | $0 (2018) |
| Agios Pharmaceuticals, Inc. | $36.21 | 1 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $26.43 | 1 | $0 (2024) |
| Novo Nordisk Inc | $22.84 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $21.11 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,464 | 4 | Emmaus Medical, Inc. ($2,438) |
| 2023 | $3,987 | 5 | Emmaus Medical, Inc. ($3,964) |
| 2022 | $14,108 | 15 | Emmaus Medical, Inc. ($7,459) |
| 2021 | $7,356 | 9 | Emmaus Medical, Inc. ($4,750) |
| 2018 | $130.40 | 2 | BOSTON SCIENTIFIC CORPORATION ($83.26) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $26.43 | General |
| Category: IMMUNOLOGY | ||||||
| 05/01/2024 | Emmaus Medical, Inc. | Endari (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $937.50 | General |
| Category: Sickle Cell | ||||||
| 03/14/2024 | Emmaus Medical, Inc. | Endari (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Sickle Cell | ||||||
| 01/08/2024 | Emmaus Medical, Inc. | Endari (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Sickle Cell | ||||||
| 09/26/2023 | Emmaus Medical, Inc. | Endari (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Sickle Cell | ||||||
| 03/30/2023 | Emmaus Medical, Inc. | Endari (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,687.50 | General |
| Category: Sickle Cell | ||||||
| 03/23/2023 | Emmaus Medical, Inc. | Endari (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: Sickle Cell | ||||||
| 03/03/2023 | Emmaus Medical, Inc. | Endari (Drug) | Food and Beverage | In-kind items and services | $26.99 | General |
| Category: Sickle Cell | ||||||
| 02/02/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $22.84 | General |
| 12/16/2022 | Emmaus Medical, Inc. | Endari (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $937.50 | General |
| Category: Sickle Cell | ||||||
| 12/01/2022 | Emmaus Medical, Inc. | Endari (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Sickle Cell | ||||||
| 10/31/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Honoraria | Cash or cash equivalent | $235.00 | General |
| Category: Sickle Cell Disease | ||||||
| 09/29/2022 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $36.21 | General |
| Category: Genetically Defined Disease | ||||||
| 06/21/2022 | Emmaus Medical, Inc. | Endari (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,125.00 | General |
| Category: Sickle Cell | ||||||
| 03/25/2022 | Emmaus Medical, Inc. | Endari (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $500.00 | General |
| Category: Sickle Cell | ||||||
| 03/16/2022 | Emmaus Medical, Inc. | Endari (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,875.00 | General |
| Category: Sickle Cell | ||||||
| 03/16/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $32.67 | General |
| Category: Sickle Cell Disease | ||||||
| 02/17/2022 | Emmaus Medical, Inc. | Endari (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $500.00 | General |
| Category: Sickle Cell | ||||||
| 02/09/2022 | Emmaus Medical, Inc. | Endari (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Sickle Cell | ||||||
| 01/18/2022 | Emmaus Medical, Inc. | Endari (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Sickle Cell | ||||||
| 01/11/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $940.00 | General |
| Category: Sickle Cell Disease | ||||||
| 01/08/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $2,115.00 | General |
| Category: Sickle Cell Disease | ||||||
| 01/07/2022 | Emmaus Medical, Inc. | Endari (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Sickle Cell | ||||||
| 01/05/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $3,290.00 | General |
| Category: Sickle Cell Disease | ||||||
| 12/08/2021 | Emmaus Medical, Inc. | Endari (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Sickle Cell | ||||||
About Dr. Brian Berman, MD
Dr. Brian Berman, MD is a Pediatric Hematology-Oncology healthcare provider based in Detroit, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043232523.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Berman, MD has received a total of $28,046 in payments from pharmaceutical and medical device companies, with $2,464 received in 2024. These payments were reported across 35 transactions from 8 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($18,563).
Ad
Practice Information
- Specialty Pediatric Hematology-Oncology
- Location Detroit, MI
- Active Since 07/24/2006
- Last Updated 02/04/2021
- Taxonomy Code 2080P0207X
- Entity Type Individual
- NPI Number 1043232523
Products in Payments
- Endari (Drug) $18,611
- OXBRYTA (Drug) $9,198
- GENERAL DBS (Device) $83.26
- iPro2 (Device) $47.14
- PYRUKYND (Drug) $36.21
- CUVITRU (Biological) $26.43
- ADAKVEO (Biological) $21.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Hematology-Oncology Doctors in Detroit
Dr. Michael Callaghan, M.d, M.D
Pediatric Hematology-Oncology — Payments: $794,158
Pediatric Hematology-Oncology $794,158
Dr. Gianna Valenti, Md, MD
Pediatric Hematology-Oncology — Payments: $1,964
Pediatric Hematology-Oncology $1,964
Bulent Ozgonenel, M.d, M.D
Pediatric Hematology-Oncology — Payments: $744.24
Pediatric Hematology-Oncology $744.24
Aghiad Chamdin, Md, MD
Pediatric Hematology-Oncology — Payments: $503.52
Pediatric Hematology-Oncology $503.52
Sarah Ramiz, M.d, M.D
Pediatric Hematology-Oncology — Payments: $361.82
Pediatric Hematology-Oncology $361.82
Rasha Mohammed I Deebajah, Md, MD
Pediatric Hematology-Oncology — Payments: $21.92
Pediatric Hematology-Oncology $21.92